CD40 and intrahepatic cholangiocarcinoma: Experimental observations further revealed that CD40-mediated immune cell activation enhanced the anti-PD-1 response in ICC mice, indicating that targeting stimulatory immune checkpoints can also enhance the blocking effect of PD-1 inhibitors.